CS MEDICA A/S Stock

Equities

End-of-day quote NORDIC GROWTH MARKET Other stock markets 18:00:00 2024-05-12 EDT			5-day change	1st Jan Change
7.043 ^DKK	+12.63%		+12.81%	+50.40%

04-30	CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	CI
04-22	CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	CI

Duration

Period

Style

CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany	04-30	CI
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy	04-22	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Apr 12, 2024	04-12
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04-04	CI
Transcript : CS Medica A/S, 2023 Earnings Call, Feb 21, 2024	02-21
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan	02-20	CI
CS Medica Obtains Danish Patent for Wound Healing Gel	02-02	MT
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia	01-26	MT
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market	12-27	CI
Transcript : CS Medica A/S, Q4 2023 Earnings Call, Dec 05, 2023	12-05
CS Medica A/S Announces Financial Year Change	11-22	CI
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023	11-22	CI
CS Medica A/S Reports Earnings Results for the Full Year Ended September 30, 2023	11-22	CI
CS Medica's Nasal Protect Gel Secures Second Patent in Denmark	23-10-31	MT
Cs Medica A/S Announces Indian State's Fda Approval for Two Cosmetic Products	23-10-12	CI

04-12

CS MEDICA Aligns Financial Priorities: Transition to Calendar Year 2024 Postponed	05-07	AQ
CS MEDICA A/S Enters New Partnership with Award-Winning OTC Company Holding a Strong Position in the Chronic Pain Segment in Germany	04-30	AQ
CS MEDICA A/S: CEO, Lone Henriksen, buys shares in the Company	04-25	AQ
CS MEDICA Advances Global Reach with 180˚ Drug Store Alliance, Powered by Pull Market Strategy.	04-22	AQ
CS MEDICA A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia	04-04	AQ